[1] |
MILLER K D, SIEGEL R L, LIN C C, et al. Cancer treatment and survivorship statistics, 2016[J]. CA A Cancer J Clin, 2016, 66(4): 271-289.
doi: 10.3322/caac.21349
|
[2] |
ZWIRNER K, THORWARTH D, WINTER R M, et al. Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup[J]. Strahlentherapie Und Onkologie, 2018, 194(8): 719-726.
doi: 10.1007/s00066-018-1292-4
|
[3] |
FAKHRY C, WESTRA W H, LI S G, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial[J]. J Natl Cancer Inst, 2008, 100(4): 261-269.
doi: 10.1093/jnci/djn011
|
[4] |
LIU Q H, WANG X B, WANG P, et al. Comparison between sonodynamic effect with protoporphyrin Ⅸ and hematoporphyrin on sarcoma 180[J]. Cancer Chemother Pharmacol, 2007, 60(5): 671-680.
doi: 10.1007/s00280-006-0413-4
|
[5] |
JOHNSON D E, BURTNESS B, LEEMANS C R, et al. Head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2020, 6: 92.
doi: 10.1038/s41572-020-00224-3
|
[6] |
FERLAY J, COLOMBET M, SOERJOMATARAM I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953.
doi: 10.1002/ijc.31937
|
[7] |
ISAYEVA T, LI Y F, MASWAHU D, et al. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review[J]. Head Neck Pathol, 2012, 6(Suppl 1): S104-S120.
|
[8] |
STEIN A P, SAHA S, KRANINGER J L, et al. Prevalence of human papillomavirus in oropharyngeal cancer[J]. Cancer J, 2015, 21(3): 138-146.
doi: 10.1097/PPO.0000000000000115
|
[9] |
NOCINI R, MOLTENI G, MATTIUZZI C, et al. Updates on larynx cancer epidemiology[J]. Chin J Cancer Res, 2020, 32(1): 18-25.
doi: 10.21147/j.issn.1000-9604.2020.01.03
|
[10] |
GROOME P A, O'SULLIVAN B, IRISH J C, et al. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States[J]. J Clin Oncol, 2003, 21(3): 496-505.
doi: 10.1200/JCO.2003.10.106
|
[11] |
ZIENTAL D, CZARCZYNSKA-GOSLINSKA B, MLYNARCZYK D T, et al. Titanium dioxide nanoparticles: prospects and applications in medicine[J]. Nanomaterials (Basel), 2020, 10(2): 387.
doi: 10.3390/nano10020387
|
[12] |
CHEN B, ZHENG R N, LIU D, et al. The tumor affinity of chlorin e6 and its sonodynamic effects on non-small cell lung cancer[J]. Ultrason Sonochemistry, 2013, 20(2): 667-673.
doi: 10.1016/j.ultsonch.2012.09.008
|
[13] |
黄苏苏, 谢波, 凌家俊, 等. 二氢卟吩e6磁性声敏纳米脂质体的制备及质量评价[J]. 中国实验方剂学杂志, 2017, 23(8): 21-26.
|
|
HUANG S S, XIE B, LING J J, et al. Preparation and quality evaluation of chlorin e6 magnetic sound sensitive nano-liposomes[J]. Chin J Exp Tradit Med Formulae, 2017, 23(8): 21-26.
|
[14] |
MCHALE A P, CALLAN J F, NOMIKOU N, et al. Sonodynamic therapy: concept, mechanism and application to cancer treatment[J]. Adv Exp Med Biol, 2016, 880: 429-450.
|
[15] |
QIAN X Q, ZHENG Y Y, CHEN Y. Micro/nanoparticle-augmented sonodynamic therapy (SDT): breaking the depth shallow of photoactivation[J]. Adv Mater, 2016, 28(37): 8097-8129.
doi: 10.1002/adma.201602012
|
[16] |
ROSENTHAL I, SOSTARIC J Z, RIESZ P. Sonodynamic therapy: a review of the synergistic effects of drugs and ultrasound[J]. Ultrason Sonochem, 2004, 11(6): 349-363.
doi: 10.1016/j.ultsonch.2004.03.004
|
[17] |
SON S, KIM J H, WANG X W, et al. Multifunctional sonosensitizers in sonodynamic cancer therapy[J]. Chem Soc Rev, 2020, 49(11): 3244-3261.
doi: 10.1039/C9CS00648F
|
[18] |
张彦军, 李增发. 声动力学疗法的抗癌机理[J]. 医疗装备, 1998, 11(9): 1-3.
|
|
ZHANG Y J, LI Z F. Analysis of the mechanism of SDT in anti-tumor effect[J]. Med Equip, 1998, 11(9): 1-3.
|
[19] |
景姣姣, 王新, 李倩玉, 等. 声敏剂的构效关系研究进展[J]. 中国药房, 2017, 28(28): 4000-4003.
|
|
JING J J, WANG X, LI Q Y, et al. Research progress of structure-activity relationship of sound sensitive agents[J]. China Pharm, 2017, 28(28): 4000-4003.
|
[20] |
STEUER C E, EL-DEIRY M, PARKS J R, et al. An update on larynx cancer[J]. CA Cancer J Clin, 2017, 67(1): 31-50.
doi: 10.3322/caac.21386
|
[21] |
KITAMURA N, SENTO S, YOSHIZAWA Y, et al. Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma[J]. Int J Mol Sci, 2020, 22(1): 240.
doi: 10.3390/ijms22010240
|
[22] |
LOO C, LOWERY A, HALAS N, et al. Immunotargeted nanoshells for integrated cancer imaging and therapy[J]. Nano Lett, 2005, 5(4): 709-711.
doi: 10.1021/nl050127s
|
[23] |
ALI I, RAHIS-UDDIN, SALIM K, et al. Advances in nano drugs for cancer chemotherapy[J]. Curr Cancer Drug Targets, 2011, 11(2): 135-146.
doi: 10.2174/156800911794328493
|
[24] |
张传忠. 压电材料的发展及应用[J]. 压电与声光, 1993, 15(3): 64-70.
|
|
ZHANG C Z. Development of piezoelectric materials and their applications[J]. Piezoelectrics Acoustooptics, 1993, 15(3): 64-70.
|
[25] |
田中华, 黄明春, 冷静. 纳米声敏剂在声动力疗法中的研究进展[J]. 中国现代应用药学, 2019, 36(8): 1018-1022.
|
|
TIAN Z H, HUANG M C, LENG J. Advances of nano-sonosensitizers in sonodynamic therapy[J]. Chin J Mod Appl Pharm, 2019, 36(8): 1018-1022.
|
[26] |
KAMINSKYY V O, ZHIVOTOVSKY B. Free radicals in cross talk between autophagy and apoptosis[J]. Antioxid Redox Signal, 2014, 21(1): 86-102.
doi: 10.1089/ars.2013.5746
|
[27] |
堵建岗, 劳力民. 光动力学结合声动力学治疗对小鼠鳞癌细胞超微结构的影响[J]. 激光生物学报, 2015, 24(4): 331-334.
|
|
DU J G, LAO L M. Effect of sono-photodynamic combination therapy on the ultrastructure of squamous cell carcinoma in mice[J]. Acta Laser Biol Sin, 2015, 24(4): 331-334.
|
[28] |
ZHAO Y, HU X B, LIU Y J, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway[J]. Mol Cancer, 2017, 16(1): 79.
doi: 10.1186/s12943-017-0648-1
|